Asha DasWan Loo TanDuncan R. SmithNational Neuroscience Institute of SingaporeMahidol University2018-07-242018-07-242003-04-25Cancer Letters. Vol.193, No.2 (2003), 217-223030438352-s2.0-0037466467https://repository.li.mahidol.ac.th/handle/20.500.14594/20741Survivin is a recently characterised inhibitor of apoptosis protein that has been implicated in the pathogenesis of several types of solid organ cancer. This study sought to describe the expression of survivin in a cohort of 90 benign meningiomas, together with the pattern of expression of other genes involved in the apoptotic process, namely bax and bcl2. Survivin expression was noted in 94% (85/90) of samples and was not correlated with the expression of either bax or bcl2 or with clinicopathological factors. © 2003 Elsevier Science Ltd. All rights reserved.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyArticleSCOPUS10.1016/S0304-3835(02)00741-3